Estadístiques de Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

Visites totals

views
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. 286

Visites totals per mes

views
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0

Visites al fitxer

views
troya-plo-abac.pdf(legacy) 172
troya-plo-abac.pdf 38

Vistes principals per país

views
United States 204
France 21
Germany 13
Ireland 10
Sweden 6
Australia 4
China 4
Spain 4
United Kingdom 4
Belgium 2
Canada 2
India 2
Italy 2
Russia 2
Ukraine 2
Malaysia 1
Venezuela 1
South Africa 1

Visites principals per ciutat

views
Ashburn 44
Fairfield 31
San Ramon 18
Cambridge 13
Boardman 11
Ann Arbor 10
Dublin 10
Mountain View 10
Seattle 7
Falls Church 5
Menlo Park 5
Des Moines 4
Redwood City 4
Sunnyvale 4
Beijing 3
Barcelona 2
Rezé 2
San Diego 2
Tustin 2
Caracas 1
Cardiff 1
Hyderabad 1
Indiana 1
Jacksonville 1
Kewarra Beach 1
Kuala Lumpur 1
Magdeburg 1
Montréal 1
Málaga 1
Orlando 1
Phoenix 1
Premiá De Mar 1
Redmond 1
Sacramento 1
Thane 1
Toronto 1